Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Colorectal cancer (CRC) remains a major global health burden, being ...
Patients with undetectable CD20 expression had worse outcomes with bispecific antibodies for DLBCL, highlighting the importance of target antigen expression in predicting treatment success. Real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback